Short Interest in NanoVibronix, Inc. (NASDAQ:NAOV) Drops By 94.2%

NanoVibronix, Inc. (NASDAQ:NAOV) was the target of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 95,700 shares, a decline of 94.2% from the January 31st total of 1,660,000 shares. Currently, 1.1% of the company’s stock are short sold. Based on an average daily trading volume, of 3,450,000 shares, the short-interest ratio is currently 0.0 days.

NanoVibronix Price Performance

NAOV stock traded down $0.00 during trading hours on Friday, reaching $0.35. The stock had a trading volume of 106,217 shares, compared to its average volume of 5,375,349. The stock has a 50-day simple moving average of $0.48 and a 200 day simple moving average of $0.57. NanoVibronix has a fifty-two week low of $0.31 and a fifty-two week high of $1.27. The stock has a market capitalization of $3.02 million, a PE ratio of -0.28 and a beta of 1.63.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.